Tvardi Therapeutics Inc. (TVRD)
NASDAQ: TVRD
· Real-Time Price · USD
24.70
0.08 (0.32%)
At close: Jun 16, 2025, 3:59 PM
0.32% (1D)
| Bid | 24.96 |
| Market Cap | 231.21M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -4.35M |
| EPS (ttm) | -2.25 |
| PE Ratio (ttm) | -10.98 |
| Forward PE | -6.57 |
| Analyst | Buy |
| Ask | 26.79 |
| Volume | 33,225 |
| Avg. Volume (20D) | 33,664 |
| Open | 24.62 |
| Previous Close | 24.62 |
| Day's Range | 24.43 - 25.73 |
| 52-Week Range | 8.14 - 34.31 |
| Beta | 0.25 |
About TVRD
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TVRD
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for TVRD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 weeks ago
+14.78%
Tvardi Therapeutics shares are trading higher afte...
Unlock content with
Pro Subscription
3 weeks ago
+17.95%
Tvardi Therapeutics shares are trading higher after Oppenheimer initiated coverage on the stock with an Outperform rating and announced a $65 price target.
3 weeks ago · businesswire.com
Tvardi Therapeutics to Participate in Upcoming Investor ConferencesHOUSTON--(BUSINESS WIRE)-- #IdiopathicPulmonaryFibrosis--Tvardi Therapeutics, Inc. (“Tvardi”) (NASDAQ: TVRD), a clinical-stage biopharmaceutical company focused on the development of novel, oral, smal...
